IXHL
Income statement / Annual
Last year (2025), Incannex Healthcare Limited's total revenue was $86.00 K,
an increase of 378.70% from the previous year.
In 2025, Incannex Healthcare Limited's net income was -$46.89 M.
See Incannex Healthcare Limited,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2025
|
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
| Period Ended |
06/30/2025 |
06/30/2024 |
06/30/2023 |
06/30/2022 |
06/30/2021 |
06/30/2020 |
06/30/2019 |
06/30/2018 |
06/30/2017 |
06/30/2016 |
| Operating Revenue |
$86.00 K |
$17.97 K |
$0.00 |
$0.00 |
$1.43 M |
$415.63 K |
$825.33 K |
$743.58 K |
$216.74 K |
$0.00 |
| Cost of Revenue |
$0.00
|
$0.00
|
$0.00
|
$4.36 K
|
$685.20 K
|
$309.44 K
|
$407.74 K
|
$384.98 K
|
$396.90 K
|
$0.00
|
| Gross Profit |
$86.00 K
|
$17.97 K
|
$0.00
|
-$4.36 K
|
$740.54 K
|
$106.19 K
|
$417.58 K
|
$358.59 K
|
-$180.17 K
|
$0.00
|
| Gross Profit Ratio |
1
|
1
|
0
|
0
|
0.52
|
0.26
|
0.51
|
0.48
|
-0.83
|
0
|
| Research and Development Expenses |
$10.75 M
|
$19.28 M
|
$6.31 M
|
$3.70 M
|
$3.57 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| General & Administrative Expenses |
$12.74 M
|
$23.98 M
|
$6.68 M
|
$5.11 M
|
$2.51 M
|
$1.23 M
|
$1.33 M
|
$1.82 M
|
$1.68 M
|
$383.57 K
|
| Selling & Marketing Expenses |
$390.00 K
|
$1.58 M
|
$1.25 M
|
$1.89 M
|
$3.27 M
|
$279.13 K
|
$493.64 K
|
$864.65 K
|
$422.96 K
|
$0.00
|
| Selling, General & Administrative Expenses |
$13.13 M
|
$25.56 M
|
$7.92 M
|
$7.00 M
|
$5.77 M
|
$1.51 M
|
$1.83 M
|
$2.68 M
|
$2.11 M
|
$383.57 K
|
| Other Expenses |
$0.00
|
$154.20 K
|
-$595.00 K
|
-$10.70 M
|
-$28.18 K
|
$1.45 M
|
$544.88 K
|
$40.13 K
|
$13.82 M
|
$193.65 K
|
| Operating Expenses |
$23.88 M
|
$44.99 M
|
$13.64 M
|
-$4.36 K
|
$9.31 M
|
$2.96 M
|
$2.37 M
|
$2.72 M
|
$15.92 M
|
$577.22 K
|
| Cost And Expenses |
$23.88 M
|
$44.99 M
|
$13.64 M
|
$10.16 M
|
$10.00 M
|
$3.26 M
|
$2.78 M
|
$3.11 M
|
$16.32 M
|
$577.22 K
|
| Interest Income |
$62.00 K
|
$308.40 K
|
$241.00 K
|
$4.31 K
|
$2.01 K
|
$3.12 K
|
$1.14 K
|
$5.04 K
|
$7.24 K
|
$8.55 K
|
| Interest Expense |
$303.00 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$59.57 K
|
$9.46 K
|
$38.27 K
|
$60.81 K
|
| Depreciation & Amortization |
$246.00 K
|
$154.20 K
|
$88.00 K
|
$0.00
|
$0.00
|
$36.54 K
|
$29.33 K
|
$40.13 K
|
$23.71 K
|
$0.00
|
| EBITDA |
-$48.09 M |
-$27.70 M |
-$13.55 M |
-$10.16 M |
-$8.57 M |
-$2.81 M |
-$1.92 M |
-$2.31 M |
-$16.07 M |
-$599.81 K |
| EBITDA Ratio |
-559.21
|
-1542
|
0
|
0
|
-6.01
|
-6.77
|
-2.33
|
-3.11
|
-74.16
|
0
|
| Operating Income Ratio |
-276.62
|
-2503.42
|
0
|
0
|
-6.01
|
-6.85
|
-2.37
|
-3.18
|
-74.3
|
0
|
| Total Other Income/Expenses Net |
-$23.10 M
|
$17.38 M
|
-$35.17 M
|
-$88.30 K
|
$28.74 K
|
$149.22 K
|
-$57.17 K
|
$4.96 K
|
-$31.03 K
|
-$83.41 K
|
| Income Before Tax |
-$46.89 M
|
-$27.59 M
|
-$48.81 M
|
-$10.25 M
|
-$8.54 M
|
-$2.70 M
|
-$2.01 M
|
-$2.36 M
|
-$16.13 M
|
-$660.63 K
|
| Income Before Tax Ratio |
-545.17
|
-1535.75
|
0
|
0
|
-5.99
|
-6.5
|
-2.44
|
-3.17
|
-74.44
|
0
|
| Income Tax Expense |
-$1.76 M
|
$44.91 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
-$105.98 K
|
-$193.40 K
|
-$234.15 K
|
-$68.73 K
|
| Net Income |
-$46.89 M
|
-$27.63 M
|
-$48.81 M
|
-$10.25 M
|
-$8.54 M
|
-$3.23 M
|
-$1.90 M
|
-$2.17 M
|
-$15.90 M
|
-$591.89 K
|
| Net Income Ratio |
-545.17
|
-1538.25
|
0
|
0
|
-5.99
|
-7.77
|
-2.31
|
-2.91
|
-73.36
|
0
|
| EPS |
-1.36 |
-1.14 |
-3.17 |
-0.0346 |
-0.0349 |
-0.0159 |
-0.009 |
-0.0383 |
-0.5 |
-0.035 |
| EPS Diluted |
-1.36 |
-1.14 |
-3.17 |
-0.0346 |
-0.0349 |
-0.0159 |
-0.009 |
-0.0383 |
-0.5 |
-0.035 |
| Weighted Average Shares Out |
$34.45 M
|
$16.16 M
|
$15.39 M
|
$297.79 M
|
$244.50 M
|
$171.01 M
|
$111.86 M
|
$57.00 M
|
$31.91 M
|
$15.69 M
|
| Weighted Average Shares Out Diluted |
$34.45 M
|
$16.16 M
|
$15.39 M
|
$297.79 M
|
$244.50 M
|
$171.01 M
|
$111.86 M
|
$57.00 M
|
$31.91 M
|
$15.69 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
